From Medscape Psychiatry

Coverage from the

American Psychiatric Association (APA) 2019

May 18 - 22, 2019; San Francisco, California

May 18 - 22, 2019 San Francisco, California
  • APA 2019 Psychedelic Cuts Cravings, Consumption in Alcohol Use Disorder Preliminary study results are promising, and the study represents a new wave of research into psychedelic drugs and various psychiatric conditions.
  • Experts Go Toe-to-Toe Over Esketamine Depression Study The ongoing debate over the risks and benefits of recently approved esketamine nasal spray for treatment-resistant depression spilled over into a heated discussion at the APA 2019 Annual Meeting.
  • CBD Gel Promising for Fragile X Syndrome A clear transdermal cannabidiol (CBD) gel improved emotional and behavioral symptoms in children and adolescents with fragile X syndrome and was well tolerated in a phase 2 study.

Conference News

Popular News from APA 2018

Medscape Psychiatry© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage